MON-LB9 Cyclic Progesterone Therapy in Androgenic Polycystic Ovary Syndrome (PCOS) - Person-Related 6-Month Experience Changes

Endometrial cancer(1) and oligomenorrhea(2) are common risks for women living with androgenic PCOS (WLWP); cyclic progesterone therapy could prevent both. Cyclic oral micronized progesterone therapy (Cyclic OMP; 300 mg at hs/14 days/cycle) also corrects the neuroendocrine origins of PCOS(3). Althoug...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Endocr Soc
Main Authors: Shirin, Sonia, Murray, Faye, Hajjaran, Maryam, Goshtasebi, Azita, Kalidasan, Dharani, Prior, Jerilynn C
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2020
Fag:
Reproductive Endocrinology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7208794/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.2332
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker